FigureĀ 2.
Time to progression (TTP) to MM. (A) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence of a normal or abnormal sFLC ratio. (B) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence or absence of minimal marrow involvement. (C) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence or absence of HR FISH abnormalities. (D) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence or absence of gain 1q and del 17p cytogenetic abnormalities.

Time to progression (TTP) to MM. (A) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence of a normal or abnormal sFLC ratio. (B) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence or absence of minimal marrow involvement. (C) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence or absence of HR FISH abnormalities. (D) Kaplan-Meier curves comparing the TTP to MM for patients with SBP based on the presence or absence of gain 1q and del 17p cytogenetic abnormalities.

Close Modal

or Create an Account

Close Modal
Close Modal